Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
5.89
-0.02 (-0.25%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.94 | 1.64 | 3.34 | 3.87 | 6.96 | 20.48 |
Short-Term Investments | 0 | 0.01 | 0.01 | 0 | 0 | 0.02 |
Cash & Short-Term Investments | 0.94 | 1.64 | 3.35 | 3.87 | 6.96 | 20.5 |
Cash Growth | -66.90% | -50.91% | -13.40% | -44.45% | -66.05% | 9.29% |
Accounts Receivable | 0.03 | 0.02 | 0.02 | 0.11 | 0.42 | 0.16 |
Other Receivables | - | - | - | 0.04 | 0.18 | 0.16 |
Total Trade Receivables | 0.03 | 0.02 | 0.02 | 0.15 | 0.6 | 0.32 |
Other Current Assets | 0.22 | 0.02 | 0.18 | 0.22 | 0.27 | 1.12 |
Total Current Assets | 1.19 | 1.68 | 3.54 | 4.23 | 7.83 | 21.94 |
Net Property, Plant & Equipment | 0.1 | 0.03 | 0.04 | 0.35 | 0.4 | 0.54 |
Long-Term Investments | 2.96 | 4.14 | 7.09 | 0.05 | 0.05 | 0.06 |
Other Long-Term Assets | 0.51 | 0.51 | - | - | - | - |
Total Assets | 4.76 | 6.36 | 10.68 | 4.64 | 8.28 | 22.54 |
Accounts Payable | 1.1 | 1.19 | 0.79 | 2.38 | 3 | 3.85 |
Current Portion of Leases | 0.08 | 0.01 | 0.01 | 0.27 | 0.29 | 0.29 |
Unearned Revenue | - | - | - | 0.23 | - | - |
Other Current Liabilities | 0.05 | - | - | - | - | - |
Total Current Liabilities | 1.22 | 1.2 | 0.8 | 2.89 | 3.28 | 4.13 |
Long-Term Leases | 0.03 | 0.03 | 0.03 | 0.07 | 0.09 | 0.19 |
Other Long-Term Liabilities | 0.23 | 0.37 | 0.16 | 0.53 | - | 1.28 |
Total Long-Term Liabilities | 0.25 | 0.4 | 0.2 | 0.6 | 0.09 | 1.48 |
Total Liabilities | 1.47 | 1.6 | 1 | 3.5 | 3.37 | 5.61 |
Common Stock | 2.19 | 2.19 | 1.84 | 1.84 | 1.15 | 49.27 |
Treasury Stock | -1 | -1.01 | -0.87 | -0.91 | -6.28 | -11.7 |
Additional Paid-in Capital | 331.98 | 331.93 | 331 | 330.81 | 334.13 | 283.98 |
Accumulated Other Comprehensive Income | 31.92 | 31.76 | 31.06 | 29.81 | 25.77 | 24.44 |
Retained Earnings | -361.8 | -360.09 | -353.36 | -360.42 | -349.86 | -329.06 |
Shareholders' Equity | 3.29 | 4.77 | 9.68 | 1.15 | 4.91 | 16.93 |
Total Liabilities & Equity | 4.76 | 6.36 | 10.68 | 4.64 | 8.28 | 22.54 |
Total Debt | 0.1 | 0.03 | 0.04 | 0.34 | 0.37 | 0.48 |
Net Cash (Debt) | 0.84 | 1.61 | 3.31 | 3.52 | 6.59 | 20.02 |
Net Cash Growth | -48.09% | -51.33% | -6.13% | -46.53% | -67.10% | 10.04% |
Net Cash Per Share | 0.89 | 1.80 | 4.04 | 5.69 | 9.61 | 70.41 |
Book Value | 3.29 | 4.77 | 9.68 | 1.15 | 4.91 | 16.93 |
Book Value Per Share | 3.51 | 5.33 | 11.84 | 1.85 | 7.17 | 59.55 |
Tangible Book Value | 3.29 | 4.77 | 9.68 | 1.15 | 4.91 | 16.93 |
Tangible Book Value Per Share | 3.51 | 5.33 | 11.84 | 1.85 | 7.17 | 59.55 |